Status:
COMPLETED
A Behavioral Intervention for Depression and Chronic Pain in Primary Care
Lead Sponsor:
Weill Medical College of Cornell University
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Chronic Pain
Depression
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
Chronic pain and depression frequently co-exist in late and mid-life and contribute to increased disability, high health care costs, psychiatric comorbidity, and suicide. The investigators will recrui...
Eligibility Criteria
Inclusion
- Age 50 years
- PHQ-9 greater than or equal to 10
- Non-cancer related chronic pain, defined as pain during most days over the past 3 months by patient report
- Capacity to consent
Exclusion
- DSM-5 Axis 1 other than depression and anxiety disorders
- Montreal Cognitive Assessment (MoCA) \< 24
- Active suicidal ideation, i.e. MADRS Suicide Item greater than or equal to 4
- Severe or life-threatening medical illness.
- Patients on psychotropics, opioids or benzodiazepines will be included if they do not meet DSM-5 criteria for opioid, anxiolytics or other substance abuse disorders
Key Trial Info
Start Date :
February 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 22 2022
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT03265210
Start Date
February 1 2018
End Date
February 22 2022
Last Update
March 3 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Cornell Internal Medicine Associates (WCIMA)
New York, New York, United States, 10021
2
Iris Cantor Men's & Women's Health Centers
New York, New York, United States, 10065
3
Irving Sherwood Wright Center
New York, New York, United States, 10075